Similar Search Results

Measuring the Externality of Antibacterial Use from Promoting Antimicrobial Resistance

Kaier, Klaus; Frank, Uwe - In: PharmacoEconomics 28 (2010) 12, pp. 1123-1128

Background: The emergence and spread of antimicrobial resistance (AMR) has become a serious public health threat … prioritizing prevention methods. …

Persistent link: https://www.econbiz.de/10008725817

Influenza Vaccination in Healthy Working Adults in Russia: Observational Study of Effectiveness and Return on Investment for the Employer

At'kov, O. Yu. Atkov; Azarov, A.V.; Zhukov, D.A.; … - In: Applied Health Economics and Health Policy 9 (2011) 2, pp. 89-99

Background: All age groups are affected by influenza infection, resulting in significant medical and economic burden. Influenza infection of healthy working adults can have a marked effect on companies due to lost work days and reduced productivity. Studies in corporate settings have shown that...

Persistent link: https://www.econbiz.de/10010614270

The Impact of CT Colonography for Colorectal Cancer Screening on the UK NHS: Costs, Healthcare Resources and Health Outcomes

Sweet, Alison; Lee, David; Gairy, Kerry; Phiri, Denver; … - In: Applied Health Economics and Health Policy 9 (2011) 1, pp. 51-64

programme for CRC on key health outcomes as well as the NHS budget and healthcare resource capacity. Abstract: Methods … (biennial FOBT with and without CTC triage of patients referred to OC, and CTC every 5 years) on a range of health outcomes …, including the incidence and prevalence of CRC, in a hypothetical cohort of individuals. The yearly costs, health outcomes and …

Persistent link: https://www.econbiz.de/10010614282

Cost Effectiveness of Pneumococcal Conjugate Vaccination against Acute Otitis Media in Children: A Review

Boonacker, Chantal W.B.; Broos, Pieter H.; Sanders, … - In: PharmacoEconomics 29 (2011) 3, pp. 199-211

of Abstracts of Reviews of Effects [DARE], NHS Economic Evaluation Database [NHS EED] and Health …

Persistent link: https://www.econbiz.de/10010614297

Rotavirus Vaccine RIX4414 (Rotarix™): A Pharmacoeconomic Review of its Use in the Prevention of Rotavirus Gastroenteritis in Developing Countries

Plosker, Greg L. - In: PharmacoEconomics 29 (2011) 11, pp. 989-1009

This article provides an overview of the clinical profile of rotavirus vaccine RIX4414 (Rotarix™) in the prevention of …

Persistent link: https://www.econbiz.de/10010614303

The Authors' Reply

Kapoor, Alok; Radhakrishnan, Nila; Smith, Kenneth J. - In: PharmacoEconomics 28 (2010) 9, pp. 782-784

Persistent link: https://www.econbiz.de/10010614307

The Authors' Reply

McCullagh, Laura; Tilson, Lesley; Walsh, Cathal; Barry, … - In: PharmacoEconomics 28 (2010) 9, pp. 784-785

Persistent link: https://www.econbiz.de/10010614318

Posaconazole: A Pharmacoeconomic Review of its Use in the Prophylaxis of Invasive Fungal Disease in Immunocompromised Hosts

Lyseng-Williamson, Katherine A. - In: PharmacoEconomics 29 (2011) 3, pp. 251-268

Posaconazole (Noxafil) is an oral, second-generation, extended-spectrum triazole whose approved indications include prophylaxis of invasive fungal disease (IFD) in immunocompromised patients. In pivotal head-to-head trials, posaconazole was significantly more effective in preventing IFD than...

Persistent link: https://www.econbiz.de/10010614335

Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement:: A Systematic Review

Plumb, Jonathan M.; Clemens, Andreas; Monz, Brigitta U. - In: PharmacoEconomics 28 (2010) 9, pp. 781-782

Persistent link: https://www.econbiz.de/10010614396

Cost Effectiveness of Venous Thromboembolism Pharmacological Prophylaxis in Total Hip and Knee Replacement: A Systematic Review

Kapoor, Alok; Chuang, Warren; Radhakrishnan, Nila; … - In: PharmacoEconomics 28 (2010) 7, pp. 521-538

Total hip and knee replacements (THR and TKR) are high-risk settings for venous thromboembolism (VTE). This review summarizes the cost effectiveness of VTE prophylaxis regimens for THR and TKR. We searched MEDLINE (January 1997 to October 2009), EMBASE (January 1997 to June 2009) and the UK NHS...

Persistent link: https://www.econbiz.de/10008505440